Pharma Pathway

MARCH 3, 2023

Hetero Labs Limited-Walk-In Interviews for Freshers & Experienced in QC -Instrumentation On 4th Mar’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Dear, Greetings from Hetero…!!

Biosimilars 80

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 80

Pharma Pathway

FEBRUARY 20, 2023

Hetero Labs Limited-Walk-In Interviews for Freshers in Production/ QA/ QC/ Maintenance On 21st Feb’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”.

Biosimilars 78

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 78

Pharma Pathway

FEBRUARY 3, 2023

Hetero Labs Limited-Walk-In Interviews for Freshers & Experienced in Production/Packing/ QA/ Stores On 4th Feb’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”.

Biosimilars 82

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 82

Pharma Pathway

FEBRUARY 4, 2023

Walk-In Interviews for fresher -Apprentice Trainee On 8th Feb’ 2023 Job Description Dr. Reddy’s Laboratories Ltd. is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Walk-In Interviews for fresher -Apprentice Trainee On 8th Feb’ 2023

Biosimilars 86

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 86

Pharma Pathway

FEBRUARY 2, 2023

Hetero Labs Limited-Walk-In Interviews for Freshers in Quality Control/ Quality Assurance/ Production On 5th Feb’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Chemist Qualification: B.Sc

Biosimilars 80

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 80

Pharma Pathway

FEBRUARY 16, 2023

in Regulatory Affairs On 17th Feb’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Hetero’s business includes APIs, generic, biosimilars, custom pharmaceutical services, and branded generics.

Biosimilars 72

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 72

Pharma Pathway

JANUARY 30, 2023

Hetero Labs Limited-Walk-In Interviews for Freshers in QA/ QC/ Production On 3rd Feb’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Hetero also offers custom pharmaceutical services to its partners around the world.

Biosimilars 72

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 72

Pharma Pathway

JANUARY 24, 2023

Hetero Labs Limited-Walk-In Interviews for Quality Control/ Quality Assurance/ Engineering/ Safety -EHS On 29th Jan’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”.

Biosimilars 74

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 74

Pharma Pathway

JANUARY 5, 2023

Walk-In Drive for Multiple Positions On 8th Jan’ 2023. is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three business-Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products. Job Description.

Biosimilars 86

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 86

Pharma Pathway

JANUARY 26, 2023

Hetero Labs Limited-Walk-In Interviews for Freshers in QC/ QA/ R&D/ Production/ HR/ Maintenance On 29th Jan’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”.

Biosimilars 78

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 78

Pharma Pathway

JANUARY 24, 2023

Hetero Labs Limited-Walk-In Interviews for AR&D/ FR&D/ Analytical DQA On 28th Jan’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”.

Method Validation 79

Method Validation Biosimilars Pharmaceutical Companies Pharmaceutical Companies 79

Pharma Pathway

FEBRUARY 21, 2023

Hetero Labs Limited-Walk-In Interviews for Production On 26th Feb’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Hetero’s business includes APIs, generic, biosimilars, custom pharmaceutical services, and branded generics.

Biosimilars 52

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 52

Pharma Pathway

FEBRUARY 17, 2023

Hetero Labs Limited-Walk-In Drive for Any Graduate in Production- API On 19th Feb’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Hetero also offers custom pharmaceutical services to its partners around the world.

Biosimilars 52

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 52

Pharma Pathway

JANUARY 5, 2023

Hetero Labs Limited-Walk-In Interviews for Freshers & Experienced On 6th & 7th Jan’ 2023. Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Hetero also offers custom pharmaceutical services to its partners around the world.

Biosimilars 52

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 52

Pharma Pathway

JANUARY 4, 2023

On 8th Jan’ 2023. is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three business-Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products. Company Name: Dr. Reddy’s Laboratories.

Biosimilars 82

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 82

pharmaphorum

APRIL 1, 2022

Congress and the White House to curtail prescription drug prices, many experts continue to point to biosimilars and their promising potential to usher in competition, increase access, and drive down costs for patients—and the U.S. And already in the first quarter of 2022, the FDA approved a third filgrastim biosimilar, Releuko.

Biosimilars 59

Biosimilars Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 59

Pharma Pathway

FEBRUARY 4, 2023

Hetero Labs Limited-Campus Drive for B.Sc /B.Pharm/ M.Sc/ BCCA/ ITI Fitter/ Diploma/ B.Com/ Diploma Freshers On 6th Feb’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”.

Biosimilars 52

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 52

Pharma Pathway

FEBRUARY 27, 2023

Hetero Labs Limited-Walk-In Interviews for Freshers & experienced in Production/ Packing/ QC/ QA/ Stores On 4th March 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Dear, Greetings from Hetero…!!

Biosimilars 52

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 52

Express Pharma

APRIL 18, 2024

a specialty pharmaceutical company in Brazil, for the commercialisation of its vertically integrated drug product, Semaglutide (gOzempic), which is used to improve glycemic control in adults with type-2 diabetes. The post Biocon signs licensing and supply pact with Biomm S.A

Diabetes 105

Diabetes Biosimilars Pharmaceutical Companies Pharmaceutical Companies 105

European Pharmaceutical Review

FEBRUARY 27, 2024

Amgen drug development highlights – November 2023 In November 2023, Phase II trial results for immunotherapy tarlatamab demonstrated an ability to provide sustained anti-tumour activity in 40 percent of the small cell lung cancer trial patients.

Biosimilars 105

Biosimilars Pharmaceutical Companies Pharmaceutical Companies Drug Development 105

Express Pharma

OCTOBER 6, 2023

Biocon has signed a partnership agreement with Juno Pharmaceuticals, a specialty pharmaceutical company in Canada, for the commercialisation of its vertically integrated, complex formulation, Liraglutide, a drug-device combination for the treatment and management of Type 2 diabetes and obesity.

Diabetes 105

Diabetes Biosimilars Pharmaceutical Companies Pharmaceutical Companies 105

Pharma Pathway

DECEMBER 7, 2022

Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Hetero’s business includes APIs, generic, biosimilars, custom pharmaceutical services, and branded generics. Time: 10:00 AM Onwards. hetero.com.

Biosimilars 87

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 87

PharmaShots

MARCH 29, 2023

Shots: Drug patent expiry is when a patent granted to a pharmaceutical company for a particular drug expires, allowing other companies to produce and sell generic versions Like every other utility patent, pharmaceuticals also get market exclusivity of 20 years. Currently, the drug is not accessible in generic form.

Biosimilars 49

Biosimilars Diabetes Chemotherapy Immunity 49

Express Pharma

JUNE 28, 2024

billion in 2023 to $17.9 However, balancing affordability and accessibility with clinical efficacy remains a challenge that pharmaceutical companies must continue to navigate.” Primarily, the loss of patent protection for several drugs, such as Evenity, will lead to the launch of more generics and biosimilars.

Biosimilars 105

Biosimilars Compounding Pharmaceutical Companies Pharmaceutical Companies 105

European Pharmaceutical Review

NOVEMBER 8, 2022

2) limiting the scope and number of patents asserted in litigation against proposed biosimilar entrants. 4) prohibiting ‘product hopping’ and interference with generic and biosimilar substitutions. 5) monitoring access to biosimilars. 3) policing anticompetitive settlements between competing drug manufacturers.

Biosimilars 52

Biosimilars Drug Pricing Pharmaceutical Manufacturing Pharmaceutical Companies 52

Pharmaceutical Technology

JANUARY 30, 2023

on National Health Service (NHS) sales of branded medicines in 2023, almost double that of the previous year, has sent shock waves through the pharma industry. Full details of the government’s 2023 VPAS payment calculation may be accessed on the UK Department of Health and Social Care (DHSC) page here. billion ($4.1

Biosimilars 97

Biosimilars Pharmaceutical Companies Pharmaceutical Companies Vaccines 97

Pharmaceutical Technology

FEBRUARY 8, 2023

Pfizer is likely to continue maintaining its position by breaking into the race for a respiratory syncytial virus (RSV) vaccine; it is currently awaiting FDA marketing approval for its RSV vaccine, which was awarded priority review with a PDUFA date decision in May 2023.

Vaccines 78

Vaccines Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 78

European Pharmaceutical Review

APRIL 13, 2023

Legislative hurdles aside, in the same way as any other pharmaceutical companies, psychedelics companies will need to obtain regulatory approvals in the countries where they will carry out clinical trials or market products. Sian Banks is a Solicitor within Pinsent Masons’ international intellectual property group.

Biosimilars 131

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 131

Express Pharma

JUNE 4, 2024

The significant growth in biosimilars approvals and manufacturing further enhances patient access to biopharmaceuticals. With strategic investments in developing generic and biopharmaceutical versions, India stands poised to maintain its global pharmaceutical leadership. Regulatory reforms are set to boost innovation and quality.

Packaging 105

Packaging Biosimilars Vaccines Labelling 105

European Pharmaceutical Review

APRIL 26, 2024

“approval [of Pyzchiva ® (biosimilar ustekinumab)] of is a crucial step towards offering European patients an additional safe and effective treatment option” Pharmaceutical company Sandoz has announced that the European Commission (EC) has granted marketing authorisation for Pyzchiva ® (biosimilar ustekinumab ).

Biosimilars 98

Biosimilars Packaging Pharmaceutical Companies Pharmaceutical Companies 98

European Pharmaceutical Review

MAY 24, 2023

Alvotech and Advanz Pharmaceutical have extended their partnership, regarding the supply and commercialisation of five proposed biosimilars in Europe. The company responsible for development and commercial supply of the biologic medicines is Alvotech, a global biotech company specialising in biosimilar treatments.

Biosimilars 98

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 98

PharmaState Academy

MAY 16, 2023

Over the next 15 to 20 years, you can expect pharma business models of today to be metamorphosed by biopharmaceuticals and biosimilars. 7) An analysis of ten pharmaceutical companies by Boston Consulting Group revealed the average production cost per pack was ca. $5 5 for small molecules and ca. $60 60 for biologics.

Biosimilars 52

Biosimilars Dosage Pharmaceutical Companies Pharmaceutical Companies 52

PharmaShots

FEBRUARY 27, 2023

Some of their thoughts are: Mr. Mekala Rao (Chairman – Technology Global PHT Expo & Summit – 2023 and President – Atachi Systems, USA) – “motivation to attend Global PHT is to understand the cultural gap in the production of innovative medicine, healthcare systems between eastern and western world.

Biosimilars 40

Biosimilars Diabetes Packaging Hospitals 40

Express Pharma

SEPTEMBER 3, 2024

A SEBI circular dated July 12, 2023 mandates that the top 150 listed entities (by market cap) had to undertake reasonable assurance of Business Responsibility and Sustainability Reporting (BRSR) Core from FY23-24, and this will extend to the top 1000 listed entities by FY26-27. For example, Shah points out that Biocon’s $1.2

Packaging 111

Packaging Biosimilars Communication Pharmaceutical Companies 111

Express Pharma

JULY 10, 2024

Brimming with potential As per an Invest India report of 2023, the Indian Bioeconomy, valued at $137 billion in 2023, is targeted to reach $150 billion by 2025 and $300 billion by 2030. IBER Report 2023 divulges, “The biopharma vaccines (non-COVID alone) market makes a significant daily contribution of approximately $38 million.

Vaccines 96

Vaccines Drug Development Process Improvement Biosimilars 96

Big Molecule Watch

JUNE 6, 2023

On May 26, 2023, the European Commission granted the marketing authorization to Samsung Bioepis for EPYSQLI, a biosimilar referencing SOLIRIS (eculizumab) developed by Alexion for the treatment of the paroxysmal nocturnal hemoglobinuria (PNH) that had global sales of approximately $5 trillion last year.

Biosimilars 57

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 57

European Pharmaceutical Review

JULY 4, 2024

4,6 Five patent issues that European biosimilar developers should consider before entering the US market Quality control of the botanical drug substances was one of the critical factors that led to barricades during the development of Veregen and Mytesi. About the author Taly Dvorkis is Life Sciences Regulatory Director at Fieldfisher.

Drug Development 103

Drug Development Biosimilars Documentation Compounding 103